On-line hemodiafiltration (OL-HDF) has established itself as a highly efficient and safe form of renal replacement therapy, providing clinical benefits for several conditions that afflict end-stage chronic kidney disease patients. Additionally, evidence now ascribes a survival benefit to OL-HDF. The first indication that mortality rates decline with high-efficiency OL-HDF was provided by the European results from the DOPPS. Since then, the RISCAVID, CONTRAST and the Turkish HDF trials have all substantiated the original findings that higher convection volumes are favorable in terms of improved survival. With the emerging concept of convection volume impacting patient survival, we examine the factors and practical approaches by which maximal convection volumes can actually be achieved and individualized for each patient treated with OL-HDF. We believe that with these factors in mind, all attempts should be made to maximize convective volume, and hence the convective dose, to enable the patient to derive the full benefits of OL-HDF over extended periods.

Keywords:
On-line hemodiafiltration, Convective volume, Patient outcomes
1.
Canaud B, N'Guyen QV, Lagarde C, Stec F, Polaschegg HD, Mion C: Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol. Basel, Karger, 1985, vol 46, pp 184-186.
2.
Van Laecke S, De Wilde K, Vanholder R: Online hemodiafiltration. Artif Organs 2006;30:579-585.
3.
Gatti E, Ronco C: Seeking an optimal renal replacement therapy for the chronic kidney disease epidemic: the case for on-line hemodiafiltration. Contrib Nephrol. Basel, Karger, 2011, vol 175, pp 170-185.
4.
Locatelli F, Manzoni C, Viagano S, Cavalli A, Di Filippo S: Hemodiafiltration - state of art. Contrib Nephrol. Basel, Karger, 2011, vol 168, pp 5-18.
5.
Locatelli F, Manzoni C, Del Vecchio L, Cavalli A, Pontoriero G: Recent trials on hemodiafiltration. Contrib Nephrol. Basel, Karger, 2011, vol 171, pp 92-100.
6.
Bowry SK: Membrane requirements for high-flux and convective therapies. Contrib Nephrol. Basel, Karger, 2011, vol 175, pp 57-68.
7.
Misra M: Basic mechanisms governing solute and fluid transport in hemodialysis. Hemodial Int 2008;12(suppl 2):S25- S28.
8.
Jaffrin MY: Convective mass transfer in hemodialysis. Artif Organs 1995;19:1162-1171.
9.
Bowry SK, Gatti E: Impact of hemodialysis therapy on anemia of chronic kidney disease: the potential mechanisms. Blood Purif 2011;32:210-219.
10.
Filiopoulos V, Hadjiyannakos D, Metaxaki P, Sideris V, Takouli L, Anogiati A, Vlassopoulos D: Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol 2008;28:949-957.
11.
Schmid H, Schiffl H: Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on. Int Urol Nephrol 2012;44:1435-1440.
12.
Canaud B, Bragg-Gresham JL, Marshall MR, et al: Mortality risk for patients receiving hemodiafiltration versus hemodialysis. European results from the DOPPS. Kidney Int 2006;69:2087-2093.
13.
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci W, Tripepi C, Tetta C, Palla R: Chronic inflammation and mortality in hemodialysis: effect of different renal replacement therapies. Results from the TSCAVID study. Nephrol Dial Transplant 2008;23:2337-2343.
14.
Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, ter Wee PM, Blankestijn PJ, CONTRAST Investigators: Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23:1087-1096.
15.
Ok E, Asci G, Sevinc-Ok E, Kircelli F, Yilmaz M, Hur E, Sezis Demirci M, Ozdogan O, Demirci C, Onen Sertoz O, Duman S, Ozkahya M, Kayikcioglu M, Elbi H, Basci A, Toz H: Comparison of postdilution on-line hemodiafiltration and hemodialysis (Turkish HDF Study). Nephrol Dial Transplant 2012 (E-pub ahead of print).
16.
Locatelli F, Canaud B: Dialysis adequacy today: a European perspective. Nephrol Dial Transplant 2012;27:3043-3048.
17.
Maduell F, Moreso F, Pons M, Ramos R, Maro-Macia, Foraster A, Soler J, Galceran JM, Martinez-Castelao A: Design and patient characteristics of ESHOL study, a Catalonian prospective randomised study. J Nephrol 2011;24:196-202.
18.
Aires I, Matias P, Dil C, Jorge C, Ferreira A: On-line haemodiafiltration with high-volume substitution fluid: long-term efficacy and security. Nephrol Dial Transplant 2007;22:286-287.
19.
Canaud B, Bowry SK: Emerging clinical evidence on online hemodiafiltration: does volume of ultrafiltration matter? Blood Purif 2013 (E-pub ahead of print).
20.
Azar AH, Canaud B: Hemodialysis system; in Azar AT (ed): Modelling and Control of Dialysis Systems. Berlin, Springer, 2012, vol 1, chapt 3, pp 99-166.
21.
Henderson LW, Colton CK, Ford CA: Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med 1975;85:372-391.
22.
Colton CK, Henderson LW, Ford CA, Lysaght MJ: Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow-fiber blood ultrafilter. J Lab Clin Med 1975;85:355-371.
23.
Mandolfo S, Borlandelli S, Imbasciati E, Badalamenti S, Graziani G, Sereni L, Varesani M, Wratten ML, Corsi A, Elli A: Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems. Hemodial Int 2008;12:55-61.
24.
Canaud B, Chenine L, Renaud S, Leray H: Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol. Basel, Karger, 2011, vol 168, pp 28-38.
25.
Spalding EM, Pandya P, Farrington K: Effect of high haematocrit on the efficiency of high-flux dialysis therapies. Nephron Clin Pract 2008;110:c86-c92.
26.
Ward RA: Blood flow rate: an important determinant of urea clearance and delivered Kt/V. Adv Ren Replace Ther 1999;6:75-79.
27.
Ward RA: Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer? Semin Dial 2011;24:65-71.
28.
Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007;22:3547-3552.
29.
Pedrini LA, Wiesen G: Overcoming the limitations of post-dilution on-line hemodiafiltration: mixed dilution hemodiafiltration. Contrib Nephrol. Basel, Karger, 2011, vol 175, pp 129-140.
30.
Tattersall JE, Ward RA on behalf of the EUDIAL Group: Online hemodiafiltration: definition, convective dose quantification and safety revisited. Nephrol Dial Transplant 2013 (E-pub ahead of print).
31.
Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, CONTRAST Investigators: Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010;55:77-87.
32.
Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R: Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009;24:562-570.
33.
Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R: Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant. 2009;24:562-570.
34.
Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003;64:305-313.
35.
Penne EL, van der Weerd NC, Bots ML, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Ter Wee PM, Blankestijn PJ, CONTRAST Investigators: Patient- and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice. Nephrol Dial Transplant 2009;24:3493-3499.
36.
Canaud B, Bosc JY, Leray H, Stec F, Argiles A, Leblanc M, Mion C: On-line haemodiafiltration: state of the art. Nephrol Dial Transplant 1998;13(suppl 5):3-11.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.